Introduction
In previous work we and others demonstrated that single and repeated exposures of human carcinoma cells to ionizing radiation result in the immediate activation of the epidermal growth factor receptor (EGFR; Schmidt-Ullrich et al., 1996; Goldkorn et al., 1997) . Stimulation of EGFR and downstream components of the mitogen-activated protein kinase (MAPK) cascade, including phospholipase, C, Ras, and Raf-1 (Kavanagh et al., 1998; Schmidt-Ullrich et al., 1997; Suy et al., 1997) , have been linked to radiation-induced proliferation (Schmidt-Ullrich et al., 1997; Kavanagh et al., 1995) , and can be considered an important cytoprotective response (Balaban et al., 1996) . This activation of the MAPK pathway through EGFR may represent a mechanism underlying previously described accelerated repopulation during repeated radiation exposures in the therapeutic dose range (Withers et al., 1988; Bentzen and Thames, 1991) .
Independent investigation has identi®ed c-Jun NH 2 -terminal protein kinase 1 (JNK1) as a downstream target of radiation-induced sphingomyelinase activation and ceramide production (Verheij et al., 1996; Jarvis et al., 1997b) . Under certain conditions, activation of JNK1 can result in apoptosis Guo et al., 1998) . On the other hand, radiation responses of the JNK1 cascade have not been de®nitively linked to speci®c receptor activation events, except for indirect evidence that ultraviolet irradiation, a potent activator of JNK1, induces clustering of TNFa receptors in the plasma membrane (Rosette and Karin, 1996) .
While ionizing radiation has been shown to stimulate multiple signal transduction responses, our understanding of the relative importance of each of the cascades for overall cellular radiation responses is limited. Thus, we have initiated a comprehensive analysis of the relationship between EGFR activation and downstream cellular responses that aect cell proliferation or apoptosis. For these studies human mammary carcinoma cell (MCC) lines were generated expressing EGFR-CD533, a dominant negative mutant of EGFR lacking the 533 COOH-terminal amino acids (Redemann et al., 1992; Spivak-Kroizman et al., 1992; Kashles et al., 1991) . Expression of EGFR-CD533, under the control of a doxycycline (Dox)-inducible promoter, converts the autocrine growth regulated MCCs into functionally negative EGFR mutants (Contessa et al., 1999; Kashles et al., 1991) . In these cells we have de®ned the eects of EGFR function on the radiation-induced activation of MAPK and JNK1. In addition, we have examined the consequences of inhibiting intracellular signaling at the levels of Ras, through farnesyltransferase inhibitors (Manne et al., 1995) , and of MAPK, using the MEK1/2 inhibitor PD98059 (Dudley et al., 1995) . These studies have yielded critical new information regarding the relative importance of two major signaling pathways on cellular radiation toxicity. They have also identi®ed Ras as a component that mediates cross-communication between the MAPK and JNK1 pathways.
Results

EGFR function and radiation-induced activation of MAPK and JNK1
The MDA-TR15-EGFR-CD533 cell line, a derivative of the parental MDA-MB-231 cell line, expresses dominant negative EGFR-CD533 (Contessa et al., 1999; Redemann et al., 1992) under the control of a two-plasmid Dox-inducible expression system (Gossen et al., 1995) . All experiments examining the role of EGFR in cellular radiation responses were performed without and with expression of the dominant negative EGFR-CD533. The maximum expression of EGFR-CD533 was achieved by exposing cells to 1 mg/ml of Dox for 48 h prior to irradiation. Analyses of signal transduction cascades were limited to immediate responses within 60 min after irradiation since radiation-induced transient activation of EGFR has been de®ned as a 1 ± 5 min transient increase in Tyr phosphorylation (Schmidt-Ullrich et al., 1996 .
In the absence of EGFR-CD533 expression, the activation of EGFR after 2 Gy of ionizing radiation mediated a maximum 1.9 (+0.04)-fold activation of MAPK within 4 min which returned to base-line levels after 60 min (Figure 1a) . After induction of EGFR-CD533 expression, the radiation-induced activation of MAPK was completely inhibited, indicating that this response depended on EGFR function (Figure 1a) .
Radiation-induced activation of JNK1 followed slightly slower kinetics with an early peak of 1.5(+0.1)-fold stimulation above basal levels at 10 min and a later rise in activity (Figure 1c) to a 1.6(+0.03)-fold increase at 60 min. The expression of EGFR-CD533 did not block the radiation-induced 1.7(+0.1)-fold activation of JNK1 at the early time points. However, the activation of JNK1 30 min after irradiation was completely ablated by expression of EGFR-CD533 (Figure 1c ). This data suggests that radiation-induced JNK1 activation occurred through both EGFR-dependent and -independent mechanisms.
Although the immediate enhancement of signals along the MAPK and JNK1 cascades were statistically Figure 1 Eects of dominant negative EGFR-CD533 expression on MAPK and JNK1 activation after a single radiation exposure of 2 Gy. MDA-TR15-EGFR-CD533 cells, a and c were treated with (*) or without (&) Dox for 48 h prior to irradiation (2 Gy) for the induction of EGFR-CD533 expression. The parental control cell line MDA-TR15, b and d, lacking a Dox inducible gene, was also treated with (*) or without (&) Dox for 48 h prior to irradiation (2 Gy). At the indicated times after irradiation, MAPK and JNK1 activities were measured and expressed relative to basal activities prior to irradiation. For experimental details see Materials and methods. (a) MAPK; (c) JNK1. The actual radioactive counts were converted into fold activation. MAPK activity at time=0 were 12 850+800 c.p.m. and 13 104+700 c.p.m. for cells without and with expression EGFR-CD533, respectively; the corresponding JNK1 activities at time=0 were 5300+850 c.p.m. and 4900+650 c.p.m. under control conditions or conditions of EGFR-CD533 expression, respectively. (b) MAPK; (d) JNK1. The actual radioactive counts converted to fold activation. MAPK activity at time=0 was 14 000+850 c.p.m. for control MDA-TR15 cells and 16 000+1600 c.p.m. for Dox treated MDA-TR15 cells; the corresponding JNK1 activities at time=0 was 4750+400 c.p.m. and 3500+300 c.p.m., respectively. The results shown give average values from three independent experiments signi®cant relative to controls, the speci®city of these ®ndings was further corroborated by parallel experiments with vector control cells MDA-TR15. As demonstrated in Figure 1b and d, the radiationinduced activation of MAPK and JNK1 was not altered by exposure of cells to Dox. Additional control experiments with MDA-TR15-Luc cells, which inducibly express luciferase instead of EGFR-CD533, con®rmed that the changes of radiation-induced MAPK and JNK1 activation were speci®c for EGFR-CD533 (data not shown).
EGFR function as a requirement for the enhanced immediate JNK1 activation under conditions of MAPK inhibition
We then explored the ability of radiation to induce JNK1 activation under conditions of preserved EGFR function but with inhibition of the MAPK pathway using the speci®c inhibitor of MEK1/2, PD98059. Data shown in Figure 2a demonstrates that pretreatment of MDA-TR15-EGFR-CD533 cells with 10 mM PD98059 inhibited 470% of radiation-induced MAPK activation. This inhibition of MAPK resulted in an overall 3.9 (+0.1)-fold increase in the immediate JNK1 response, equivalent to a twofold enhancement of JNK1 activation relative to the 1.9 (+0.1)-fold stimulation with radiation alone (Figures 1c and  2b ). The dierence of these values was statistically signi®cant (P50.01). The JNK1 response after 30 min was unaected.
The relative contributions of EGFR and MAPK to the enhanced radiation-induced JNK1 activation were further examined in experiments combining EGFR-CD533 expression and MEK1/2 inhibition (Dudley et al., 1995) . The 3.9-fold radiation-induced JNK1 activation within 10 min after MAPK inhibition ( Figure 2b ) was reduced to a 2.7 (+0.1)-fold increase upon the expression of dominant negative EGFR-CD533 (Figure 2c ). While this represents a 45% reduction of JNK1 activation, the residual 2.7-fold activation still constitutes a signi®cantly higher (P50.01) activity than the radiation-induced 1.9-fold stimulation of JNK1 in the absence of EGFR-CD533 expression (Figure 2c ).
These results suggest that signaling components downstream of MEK1/2 exerted a negative regulatory eect on the immediate JNK1 activation by radiation. Furthermore, inhibition of radiation-induced EGFR activation combined with MEK1/2 inhibition resulted in reduced JNK-1 activation (Figure 2c ) as compared to MEK1/2 inhibition alone (Figure 2b ). These results suggest that radiation-induced EGFR activation did contribute to the enhanced stimulation of JNK1 under conditions of MEK1/2 inhibition. This occurred despite our ®nding that radiation-induced EGFR signaling was not required for the immediate activation of JNK1 as shown in Figure 1c . Importantly, the results demonstrate cross-communication between the MAPK and JNK1 pathways.
The role of Ras in radiation-induced activation of MAPK and JNK1
Having demonstrated the interactions between radiation, EGFR function, and two major downstream signaling cascades, it was important to determine at which level communication between the MAPK and JNK1 pathways occurred. There is considerable evidence that growth factor receptors stimulate both MAPK and JNK1 activities via Ras (Kawasaki et al., 1996; Rausch and Marshall, 1997; Terada et al., 1997) . Ras function can be blocked by inhibiting Ras farnesylation which prevents translocation of Ras Figure 2 Eects of EGFR-CD533 expression and MEK1/2 inhibition with PD98059 on JNK1 activity after irradiation. MDA-TR15-EGFR-CD533 cells were treated with or without Dox for 48 h or with or without PD98059 for 2 h prior to irradiation (2 Gy), for EGFR-CD533 expression and MEK1/2 inhibition, respectively. At indicated times after irradiation, JNK1 and MAPK enzymatic activity was measured and expressed relative to basal activity prior to irradiation. For details see molecules to the plasma membrane (Suy et al., 1997) . Therefore, we examined the dependence of radiationinduced MAPK and JNK1 activation on Ras function.
In these experiments, Ras was inhibited by treatment of MDA-TR15-EGFR-CD533 cells with farnesyltransferase inhibitor I (FTI) 24 h prior to irradiation (Manne et al., 1995) . This was followed by quantitation of MAPK and JNK1 activities 0 ± 60 min after irradiation. Treatment with FTI inhibited Ras farnesylation and resulted in complete inhibition of radiation-induced MAPK activation (Figure 3a ). This eect was expected since EGF-and radiationdependent activation of MAPK is known to occur through an EGFR/Ras/Raf-1 signaling pathway (Schmidt-Ullrich et al., 1997; Kavanagh et al., 1998) . However, treatment with FTI also completely blocked the ability of radiation to stimulate JNK1 (Figure 3b ), suggesting that JNK1 activation after irradiation occurred via a Ras-dependent pathway.
Additional control experiments were performed to con®rm that Ras function played a role in the ability of PD98059 to potentiate JNK1 activation without irradiation. Treatment of MDA-TR15-EGFR-CD533 cells with PD98059 resulted in a transient, 1.35 (+0.02)-fold activation of JNK1 between 5 and 25 min which returned to basal level after 30 min of drug exposure. This response was completely ablated if cells were pre-incubated with FTI for 24 h (Figure 3c ). This ®nding suggests that cross-communication occurred between the MAPK and JNK1 pathways and identi®ed Ras as one of the components involved in this interaction.
Enhanced c-Jun Ser 63 phosphorylation as a result of MAPK inhibition
In order to examine in more detail the functional consequences of JNK1 activation, we quanti®ed the relative c-Jun Ser-63 phosphorylation in the NH 2 -terminal portion of c-Jun in vivo using immunoblotting with antibody speci®c for Ser-63 phosphorylated c-Jun (Kyriakis et al., 1994) . In previous experiments, the activation of JNK1 (Figures 1b and 2b ± c) was determined by an in vitro immune complex kinase assay using GST-c-Jun (aa 1 ± 139) as substrate.
Treatment of cells with PD98059 caused a 4twofold reduction in c-Jun protein levels relative to untreated cells ( Figure 4a ). Irradiation alone induced a maximal 14-fold increase of c-Jun phosphorylation at Ser-63 relative to c-Jun protein levels ( Figure 4b ), but had no signi®cant eect on steady state c-Jun protein levels over the 60 min examined (Figure 4a ). In contrast, cells irradiated after pretreatment with PD98059 demonstrated a substantial enhancement of relative Ser-63 phosphorylation as quanti®ed in Figure 4b . This Ser-63 phosphorylation was most pronounced 10 min after irradiation, resulting in a 41-fold increase in c-Jun protein phosphorylation relative to c-Jun protein level. This ®vefold greater stimulation of c-Jun phosphorylation under conditions of MEK1/2 inhibition compared to radiation alone was sustained for up to 60 min. The time course of Ser-63 phosphorylation in vivo correlated well with data obtained from the in vitro immune complex kinase assay. The results demonstrate that inhibition of MAPK can redirect signals from EGFR to the JNK1 cascade and that activation of JNK1 leads to enhanced Ser63 phosphorylation of c-Jun. The eects of EGFR function, MAPK activation, and JNK-1 signaling on radiation-induced apoptosis
The eects of inhibiting radiation-induced activation of EGFR and MAPK on apoptosis after irradiation were examined in the next set of experiments. Apoptosis was assessed by the Terminal dUTP Nucleotidyl End Labeling assay (TUNEL; Gorczyca et al., 1993) under conditions of EGFR-CD533 expression or MEK1/2 inhibition 24 h after irradiation. Under control conditions, the basal apoptosis rate of MDA-TR15-EGFR-CD533 cells was 3.1 (+0.1)% (Figure 5a ). Expression of EGFR-CD533 or MEK1/2 inhibition resulted in an approximate 20% increase in basal apoptosis rates of 3.6 (+0.1)% and 3.7 (+0.1)%, respectively (P50.05). A single radiation exposure at 2 Gy increased the level of apoptosis to 5.0 (+0.1)% in untreated cells. However, irradiation of cells under conditions of EGFR-CD533 expression or MEK1/2 inhibition, resulted in signi®cantly enhanced rates of 6.4(+0.1)% and 6.3(+0.1)%, respectively (P50.05). These incremental changes in apoptosis re¯ect a synergistic eect between radiation and disruption of EGFR or MAPK functions (P50.05). The combination of EGFR-CD533 expression and MEK1/2 inhibition did not enhance the apoptotic response above the eect of either treatment alone (data not shown). These ®ndings suggest that the enhanced rate of apoptosis after EGFR-CD533 expression may be functionally linked to the inhibition of the MAPK pathway.
The role of JNK-1 signaling was also assessed with respect to radiation-induced apoptosis. In the absence of a direct inhibitor of JNK-1, the potential role of JNK-1 signaling in radiation-mediated apoptosis was examined through negative modulation of the JNK-1 substrate c-Jun. The dominant negative NH 2 -terminally truncated c-Jun, TAM 67, was expressed by infection of cells with a recombinant adenovirus, Ad-TAM 67. In previous experiments with a variety of cell lines, TAM 67 has been shown to inhibit the activation of cJun by JNK-1 including AP1-induced transcription Janulis et al., 1999; Verheij et al., 1996) . Expression of TAM67 in MDA-TR15-EGFR-CD533 cells was determined 48 h after infection with the adenovirus (Ad) by immunoblotting (data not shown). Infection of cells with Ad-null and Ad-TAM67 increased the basal rate of apoptosis to 5.7 (+0.1)% and 5.5 (+0.1)%, respectively (Figure 5b ). Surprisingly, however, irradiation of MDA-TR15-EGFR-CD533 cells expressing TAM67 did not signi®cantly blunt radiation-induced apoptosis. These results suggest that the JNK1 substrate, c-Jun, may not be the only determinant controlling radiation-induced apoptosis in mammary carcinoma cells.
In Figures 2 and 4 we demonstrated that inhibition of MEK1/2 enhanced radiation-induced JNK1 activation. Since radiation-induced apoptosis has also been linked to increased JNK1 activity (Verheij et al., 1996) , we next examined whether inhibition of MEK1/2 could potentiate radiation-induced apoptosis. It was surprising to ®nd that expression of TAM67 was unable to modulate the rate of apoptosis after irradiation under conditions of MEK1/2 inhibition (Figure 5c ). Therefore, the eects of MEK1/2 inhibition on JNK1 activation and potentiation of apoptosis in MDA-TR15-EGFR-CD533 cells can be dissociated.
The importance of EGFR and MAPK functions on cell proliferation after irradiation
An assay for cellular growth potential after irradiation was devised to assess radiation-induced cytotoxicity after repeated radiation exposures of 2 Gy (Kavanagh et al., 1995; Contessa et al., 1999) . Cells were irradiated with 2 Gy once-daily for ®ve consecutive days and cell proliferation was measured for seven consecutive days using the MTT method. The eects of radiationinduced EGFR and MAPK signaling were examined by disruption of either function through expression of EGFR-CD533 and inhibition of MEK1/2, respectively.
Expression of EGFR-CD533 alone inhibited growth of the MDA-TR15-EGFR-CD533 cells by approximately 10% during 7 days (Figure 6a, left panel) , a modest but signi®cant reduction (P50.05). However, when cells expressing EGFR-CD533 were irradiated, a 3.1(+0.1)-fold reduction in cell numbers was observed at 7 days relative to control cells with preserved EGFR function (Figure 6a, right panel) . This data suggests that EGFR protects cells from the cytotoxic eects of Similarly, treatment of MDA-TR15-EGFR-CD533 cells with PD98059 alone resulted in a moderate, but signi®cant retardation of cell growth with a 25% Figure 5 Eects of EGFR or MAPK function on radiation-induced apoptosis. Apoptosis rates of MDA-TR15-EGFR-CD533 cells with and without 2 Gy of radiation were determined after treatment with the MEK1/2 inhibitor PD98059 or expression of EGFR-CD533 or recombinant adenovirus N-terminal truncated c-Jun (Ad-TAM 67) expression. Apoptosis was assessed by TUNEL 24 h after irradiation as described in Materials and Methods. (a) Eects of radiation in conjunction with EGFR-CD533 expression or MEK1/2 on cellular apoptosis. (b) Eects of radiation in conjunction with recombinant adenovirus control (null) or Ad-TAM 67 (TAM 67) expression on apoptosis. (c) Eects of radiation on apoptosis in conjunction with TAM67 expression with and without inhibition of MEK1/2. *Conditions resulting in statistical enhancement above additivity at the P50.05 levels. Data was pooled from three separate experiments and the proportion of apoptotic cells shown+s.e.m. decrease in cell numbers on day 7 (Figure 6b , left panel) (P50.05). Irradiation of cells in the presence of the MEK1/2 inhibitor resulted in 5.0(+0.03)-fold lower cell numbers on day 7 of the growth assay (Figure 6b, right panel) , which represented an even greater enhancement of radiation toxicity than was induced by the expression of EGFR-CD533 (Figure 6b , right panel). This data strongly suggests that EGFR, via MAPK signaling, mediates an important cytoprotective eect during and after exposure to ionizing radiation. Inhibition of this response at the level of EGFR or MAPK essentially ablates the cells' proliferative capacity, thus enhancing radiation toxicity.
Discussion
The inducible expression of dominant negative EGFR-CD533 in MDA-TR15-EGFR-CD533 cells has allowed us to link radiation-induced EGFR activation to MAPK and JNK1 stimulation and to cellular responses of proliferation and death by apoptosis. These ®ndings extend previous observations with the chemical inhibitor of EGFR Tyr phosphorylation, AG1478 (Schmidt-Ullrich et al., 1997; Carter et al., 1998) , and identify EGFR activation as a critical step in radiation-induced signaling along both the MAPK and JNK1 cascades. We now demonstrate that MAPK activation in irradiated cells was linked entirely to EGFR function, whereas the early phase JNK1 radiation response was independent of EGFR function with a greater EGFR-dependence of the JNK1 response 30 min after radiation exposure.
The combined use of dominant negative EGFR-CD533 expression and MEK1/2 inhibition to block MAPK activation has yielded several important ®ndings regarding the regulation of cellular responses to ionizing radiation (see Figure 7 for schematic depiction). Inhibition of the MAPK pathway enhanced the immediate activation of JNK1 and c-Jun phosphorylation, which redirects signals from the MAPK to the JNK1 pathway after irradiation and re¯ects the ability of cross-communication between these pathways after irradiation of cells. This crosscommunication is mediated, at least in part, by Ras as a common component of both pathways, since treatment of cells with FTI disrupted all radiation signals downstream of EGFR and blocked the ability of PD98059 to enhance activation of JNK1 (Figure 7) .
The degree of MAPK and JNK1 activation after irradiation in the studies described here was smaller than what had been previously reported for growth factors, UV or ionizing radiation treatments of various cell types (Zohn et al., 1995; Antonyak et al., 1998; Gupta et al., 1997; Liu et al., 1996; Kasid et al., 1996) . The most likely explanation for these dierences is that other studies have used radiation doses between 5 and 20 Gy which may induce dierent responses than the clinically relevant dose of 2 Gy used throughout this study. We have also limited our studies to the immediate early pro®les occurring within 60 min after irradiation whereas other studies have examined later time points. Furthermore, the levels of EGFR and MAPK activation noted in our study were consistent with activation levels seen using physiological concentrations of EGF ligand . Thus our data demonstrates that low, therapeutically applied radiation doses can cause signi®cant modulations of multiple signaling pathways in mammary carcinoma cells, which we have correlated with altered cytoprotective responses.
Several studies have suggested that radiationinduced activation of JNK1 in a variety of cell types was dependent upon activation of sphingomyelinase/ ceramide production (Chmura et al., 1997; Santana et al., 1996; Haimovitz-Friedman et al., 1994; Huang et al., 1997) . Inhibition of EGFR function through expression of EGFR-CD533 did not aect the immediate activation of JNK1 by radiation, but inhibited a later rise in activity at 430 min. This demonstrates that in our system, and in contrast to previous reports (Chmura et al., 1997; Michael et al., 1997; Santana et al., 1996) , radiation-induced JNK1 activation can occur through both EGFR-dependent and -independent mechanisms. Inhibition of Ras Cell proliferation was monitored on days 1, 4, 7 after the last radiation exposure. Cell proliferation was quanti®ed as incremental cell numbers relative to those on day 1. Errors represent +s.e.m. of six individual data points from a representative experiment representative for three independent experiments function by FTI also abolished JNK1 activation following radiation exposure, suggesting that both the radiation-induced EGFR-dependent and -independent JNK1 responses involve signaling through Ras (Kawasaki et al., 1996; Terada et al., 1997) . The immediate activation of JNK1 in our system may be mediated by other growth factor receptors, although de®nite proof for this possibility awaits further investigation.
The radiation-induced immediate activation of JNK1 was seen earlier in cells expressing EGFR-CD533 (Figure 1b) . EGFR function is necessary for production of inositol trisphosphate by radiation, and thereby diglyceride (Schmidt-Ullrich et al., 1997). Diglyceride, via protein kinase C, can cause activation of the MAPK pathway and suppression of the JNK1 pathway (Chmura et al., 1997; Haimovitz-Friedman et al., 1994; Jarvis et al., 1996 Jarvis et al., , 1997a Cai et al., 1997) . In contrast, ceramide, whose production is dependent upon sphingomyelinase activation, can oppose the actions of diglyceride (Muller et al., 1998) and activate the JNK1 pathway. Thus, one other possible reason for increased JNK1 activation at earlier times is that expression of EGFR-CD533 will cause a reduction in radiation-induced diglyceride production relative to ceramide production, leading to a potentiation of JNK1 activation.
MAPK has been shown to negatively modulate Ras activity by inhibiting the function of Ras GTPexchange factors (Chen et al., 1996a; Holt et al., 1996; Langlois et al., 1995; Douville and Downward, 1997) . Several studies have suggested that inhibition of the MAPK pathway alone can lead to increased activity of the JNK1 pathway (Jarvis et al., 1997a; Carter et al., 1998) . Treatment of mammary carcinoma cells with the speci®c MEK1/2 inhibitor, PD98059, caused a rapid transient increase in JNK1 activity which was abolished when Ras function was inhibited. This data argues that MAPK activity negatively regulates JNK1 activity through its ability to inhibit signaling from Ras (Figure 7) . When radiation-induced MAPK activation was inhibited by PD98059, the observed JNK1 activation was enhanced twofold relative to irradiation alone. Thus, inhibition of MAPK also potentiated the ability of upstream stimuli to activate the JNK1 pathway via Ras.
EGFR signaling has been suggested to be both radioprotective and capable of mediating a proliferation response after repeated radiation exposures (Kwok et al., 1991; Laderoute et al., 1994; Schmidt-Ullrich et al., 1997; Wollman et al., 1994; Xia et al., 1995) . The enhanced proliferation is likely to occur through EGFR stimulation of the MAPK pathway (Figure 7 ). MEK1/2 inhibition ablated, as did expression of EGFR-CD533, the ability of cells to recover a normal proliferation response after repeated radiation exposures thus enhancing the radiation cytotoxicity in our experimental system at least threefold. In comparing these signi®cant eects on cell growth to the eects of EGFR-CD533 expression and MEK1/2 inhibition on radiation-induced apoptosis the maximally twofold increase appears relatively modest but in line with observations in other laboratories (Sakakura et al., 1996) . It is also important to recognize that only single radiation exposures of 2 Gy were used in the apoptosis experiments and that similar incremental increases of apoptosis can be expected for each additional radiation exposure. The dramatic increase in eects on cell growth and apoptosis upon repeated radiation exposures has been pointed out by other investigators (Dewey et al., 1995; Heerdt et al., 1994; Lee et al., 1997) .
The ability of ionizing radiation to increase apoptosis has been suggested to depend on radiationinduced activation of JNK1 and c-Jun. However, many of these studies have been performed with hematopoietic cells and have used radiation doses substantially higher than those used in the experiments described here (Chmura et al., 1997; Michael et al., 1997; Santana et al., 1996) . We found that in MDA-TR15-EGFR-CD533 cells over-expressing dominant negative c-Jun, TAM67, the rate of radiation-induced apoptosis was unaltered in comparison to un-infected cells or cells infected with Ad-null. This data suggests that radiation exposures at relatively low doses of 2 Gy increase apoptosis in mammary and squamous carcinoma cells (this report, Carter et al., 1998) through a c-Jun-independent mechanism(s). It is possible that JNK1-mediated apoptosis may occur through a c-Jun/AP-1-independent process. MEK1/2 inhibition potentiated radiation-induced activation of JNK1, increased c-Jun phosphorylation, and enhanced radiation-induced apoptosis. However, inhibition of cJun function by expression of TAM67 did not aect radiation-induced apoptosis under conditions of MEK1/2 inhibition. Previous studies with TAM67 have demonstrated its eectiveness of blocking eectors downstream of JNK1 (Brown et al., 1996; Chen et al., 1996b; Li et al., 1998) . Our ®nding that TAM67 did not aect the radiation-induced enhanced apoptosis suggests that pathways other than JNK1 mediated this cellular response. A likely alternative is the inhibition of MAPK which may mediate apoptosis through modulation of cell cycle regulation and DNA repair. Additional experimentation along these lines is required to de®ne the mechanism(s) by which low dose radiation causes apoptosis in carcinoma cells.
Results from the above investigation point to new therapeutic strategies to enhance radiation toxicity in autocrine growth regulated human carcinoma cells. The modulation of EGFR function or downstream eector molecules such as MAPK have been identi®ed as potential targets to disrupt cytoprotective responses and to enhance radiation toxicity.
Materials and methods
Cell lines and reagents
Mammary carcinoma cell lines, MDA-TR15, MDA-TR15-EGFR-CD533 and MDA-TR-Luc used in this study were developed in our laboratory and derived from the MDA-MB-231 cell line (Contessa et al., 1999) . The cell line MDA-TR15, was used to generate both MDA-TR15-EGFR-CD533 and MDA-TR15-Luc cell lines and was used as a negative control in the study. Treatment of MDA-TR15-EGFR-CD533 and MDA-TR15-Luc cells with 1 mg/ml Dox for 48 h induced maximum expression of dominant negative EGFR-CD533 or luciferase (Contessa et al., 1999) . Recombinant adenovirus expressing Tam 67 (Ad-TAM 67) (Brown et al., 1993; , an NH 2 -terminally truncated c-Jun which functions as a dominant negative mutant of Jun/AP-1, was obtained from Dr Micheal Birrer (National Cancer Institute, Bethesda, MD).
Antibodies (Abs) to p42 MAPK (ERK2 for IP) and JNK1 (sc-571) were from Upstate Biotechnologies, Inc. (Lake Placid, NY, USA) and Santa Cruz Biotechnologies (Santa Cruz, CA, USA), respectively. Abs to N-terminal c-Jun and Ser-63 phospho-c-Jun were obtained from New England Biolabs (Beverly, MA, USA) while C-terminal c-Jun antibody (Ab-1) was obtained from Oncogene Research Products (Cambridge, MA, USA). Myelin basic protein (MBP) as MAPK substrate (Sigma Chemical Co., St. Louis, MO, USA) was used as a stock of 10 mg/ml in H 2 O. PD98059 (Calbiochem, La Jolla, CA, USA) was prepared as a 10 mM stock in DMSO and stored at 7208C (Dudley et al., 1995) . Radiolabeled 32 P-g-ATP was from NEN-Dupont (Boston, MA, USA). Protease/phosphatase inhibitors and other chemical reagents were purchased from Sigma Chemical Co., (St. Louis, MO, USA). Farnesyltransferase inhibitor I (FTI; Calbiochem, La Jolla, CA, USA) (Manne et al., 1995) was prepared as a 1 mM stock solution in sterile PBS and stored at 7208C. GST c-Jun (aa 1 ± 139) protein expressed from a GST-Jun expression construct was puri®ed on glutathione Sepharose 4B beads (Pharmacia Biotech Inc., Piscataway, NJ, USA) according to manufacturer's instructions.
For TUNEL assays, terminal transferase and¯uorescein 12-dUTP (Boehringer Mannheim, Germany) was used with mounting media containing propidium iodide (Vector Laboratories, Inc., Burlingame, CA, USA). Detection of protein by Western blotting was performed using the Western Star Chemiluminescence kit (BioRad Laboratories, La Jolla, CA, USA).
Cell treatments and irradiation
All cells were routinely grown in RPMI1640 medium (Sigma Chemical Co., St. Louis, MO, USA) containing 5% tetracycline negative fetal calf serum (ClonTech Laboratories Inc., Palo Alto, CA, USA), RPMI/5FCS. MDA-TR15-EGFR-CD533 and MDA-TR15 cells were seeded at either 9.0610 5 or 1.7610 6 cells per 10 or 15 cm plate, respectively (Schmidt-Ullrich et al., 1997). Cells were cultured for a total of 5 days in RPMI/5FCS. On day 3, cells were exposed to RPMI/5FCS with or without 1 mM Dox. On day 4, media was replaced by low serum RPMI/0.5%FCS, with or without Dox for an additional 24 h, followed by equilibration with RPMI/0.5%FCS without Dox 2 h prior to irradiation. For treatment with PD98059, cells were seeded at densities described above and exposed to RPMI/0.5%FCS for 24 h. Thereafter, cells were exposed to RPMI/0.5%FCS containing 10 mM PD98059 2 h prior to irradiation. Cellular Ras function was inhibited by incubating cells for 24 h in 50 mM FTI prior to irradiation. For expression of Tam 67 from recombinant adenovirus cells were routinely infected at an MOI of 100 for 48 h prior to irradiation or immunoblotting.
In all radiation experiments, cells were exposed to 2 Gy of ionizing radiation at a dose rate of 1.2 Gy/min using a 60 Co source. For time course experiments, cells were irradiated and incubated at 378C for the times speci®ed. Thereafter, media was removed and cells were washed once in ice-cold PBS. Cells were immediately frozen on dry ice and stored at 7208C until further processing.
Immunoprecipitation and Western analysis
For immunochemical analyses, cells frozen at 7208C were lysed in ice-cold lysis buer, 25 mM b-glycerophosphate, pH 7.4, 25 mM Tris, pH 7.4, 10% (v/v) glycerol, 1.5 mM EGTA, 0.5 mM EDTA, 1% Triton X-100, 1 mM Na-orthovanadate, 1 mM Na-pyrophosphate, 10 mg/ml aprotinin, 10 mg/ml leupeptin, 1 mM benzamidine, 100 mg/ml PMSF. Insoluble material was removed by centrifugation at 14 000 g for 10 min, and the clari®ed protein lysates were divided equally for immunoprecipitation with antibodies against JNK1 and MAPK using established techniques (Boulton et al., 1990) . Lysates were incubated with Ab at 48C for 3 h, the agaroseAb immunoprecipitates were washed twice in lysis buer, once in lysis buer containing 0.1% Triton X-100, and once in 16 kinase buer, 25 mM b-glycerophosphate, pH 7.4, 15 mM MgCl 2 . For Western blot analyses, equal amounts of cellular protein were separated by SDS ± PAGE, electroblotted to nitrocellulose, probed with speci®c Abs against cJun protein and c-Jun phosphorylated at Ser-63, followed by chemilumescence detection. Expression of Tam 67 in MDA-TR15-EGFR-CD533 cells infected with recombinant adenovirus was determined by Western analysis using a c-Jun Ab speci®c for the COOH-terminus.
Immune complex kinase assays
Immunoprecipitates were suspended in 40 ml H 2 O containing the appropriate substrates, consisting of 20 mg MBP for MAPK and 10 mg GST-c-Jun (aa 1 ± 139) protein for JNK1. For kinase assays, 10 ml of 56 kinase buer, 125 mM bglycerophosphate, pH 7.4, 75 mM MgCl 2 , 500 mM ATP, and [ 32 P]-gATP (5000 c.p.m./pmol) was added to each immunoprecipitate and incubated with periodic vortexing at 378C for 30 min.
Phosphorylation of substrate by MAPK was measured following substrate binding to P81 assay paper (Wu et al., 1993) . Aliquots of the assay mixture were placed on P81 paper and non-speci®c binding of [ 32 P]-g-ATP removed by extensive washing in 180 mM phosphoric acid. Incorporation of 32 P into bound MBP substrate was measured by liquid scintillation spectroscopy (Beckman Instruments Inc, Schaumburg, IL, USA). For JNK1 assays (Derijard et al., 1994) , sample buer was added to the kinase mixture to stop the reaction, the samples were boiled and separated by SDS ± PAGE in 10% polyacrylamide gels. Coomassie stained GSTc-Jun(aa 1 ± 139) protein was excised from the gel, and 32 P incorporated into the bound substrate was quanti®ed by liquid scintillation spectroscopy.
TUNEL assay for apoptosis
Cells were placed at a density of 2610 4 cells into dual well slides and allowed to adhere overnight in RPMI/5FCS. Cells were then exposed, prior to irradiation, for 48 h to Dox or control solute for induction of EGFR-CD533. PD98059 at a ®nal concentration of 10 mM was added 2 h prior to irradiation at 2 Gy. Cells were infected with recombinant Ad-TAM67 for expression of Tam67 for 48 h prior to irradiation. After incubation of cells for an additional 24 h, apoptosis was assessed by TUNEL assay measuring double stranded DNA breaks (Chelliah et al., 1997) . Slides were stored at 7208C until examination by¯uorescence microscopy using a¯uorescein ®lter. Approximately 500 cells were counted for each treatment condition, and the results were compiled from three dierent experiments.
Growth rate analysis
For irradiation and control conditions, 1000 and 500 cells per well of 24-well plates were seeded, respectively. Cells were maintained in RPMI/5FCS without media change throughout the period of the experiment. After 24 h of seeding, 50% of the plates were treated with 10 mM PD98059 for 2 h while negative controls were exposed to equivalent DMSO concentrations of 1 ml/ml in RPMI/5FCS. This was followed by 2 Gy daily radiation exposures for 5 consecutive days; control cells were sham irradiated. Cell growth was determined using the 3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) assay (Denizot et al., 1986; Carmicheal et al., 1987) on days 1, 4 and 7 days following the last day of irradiation. Growth rates were quanti®ed relative to absorbance at 540 nm on day 1.
Statistical analysis
The eects of various treatments were compared using one way analysis of variance and a two tailed t-test. Dierences with a P-value of 50.05 were considered statistically signi®cant. All values and means shown are +s.e.m. from an average of at least three independent experiments. For analysis of apoptotic data a 2-squared factorial analysis of variance using the standard F-test was implemented for the determination of synergy between radiation and either PD98059 or EGFR-CD533.
Abbreviations EGFR, epidermal growth factor receptor; EGFR-CD533, dominant negative EGFR; MAP kinase, mitogen-activated protein kinase; JNK1, c-Jun NH 2 -terminal kinase; Ionizing radiation
